Company PCL, Inc.

Stocks

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 21/03/2025			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

30/12/24	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
30/08/24	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

Business description: PCL, Inc.

PCL Inc is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Companyâ€™s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Number of employees: 31

Sales by Activity: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Vitro Diagnostics-Related Business	53.68B	46.15B	37.22B	8.43B	1.25B

See all business segments

Geographical breakdown of sales: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
South Korea	3.91B	599M	28.13B	2.92B	1.17B
Other	-	-	-	138M	34.09M
Asia	-	-	-	3.87B	19.75M
Europe	-	-	-	1.48B	-
Overseas	49.77B	45.55B	9.08B	-	-

See all geographic segments

Executive Committee: PCL, Inc.

Manager	Title	Age	Since
So-Yeon Kim CEO	Chief Executive Officer	55	-
Seong-Woo Lee SAM	Sales & Marketing	42	28/03/2024
Mu-Yong So AUD	Comptroller/Controller/Auditor	53	28/03/2024
Won-Hee Jang AUD	Comptroller/Controller/Auditor	53	31/03/2025
Seung-Ki Hong AUD	Comptroller/Controller/Auditor	72	-

See PCL, INC. governance

Composition of the Board of Directors: PCL, Inc.

Director	Title	Age	Since
So-Yeon Kim BRD	Director/Board Member	55	-
Chul-Joon Kim BRD	Director/Board Member	73	-
Mu-Yong So BRD	Director/Board Member	53	28/03/2024
Seong-Woo Lee BRD	Director/Board Member	42	28/03/2024
Dae-Yeol Kim BRD	Director/Board Member	49	31/03/2023

Composition of the Board of Directors

Company details: PCL, Inc.

PCL, Inc.

99 Digital-ro 9-gil

08510, Seoul

http://www.pclchip.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PCL, INC.	-1.63%	-.--%	-.--%	-85.82%	12.12M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	+2.16%	+5.05%	+99.92%	+299.85%	4.15B
IOVANCE BIOTHERAPEUTICS, INC.	-7.79%	+18.77%	+208.18%	+31.38%	3.76B
VERACYTE, INC.	+1.24%	+2.57%	+36.48%	+61.24%	3.4B
CAREDX, INC.	+3.45%	+7.26%	+274.79%	+454.28%	2.51B
BGI GENOMICS CO., LTD.	-3.61%	+3.84%	-21.05%	-19.77%	2.41B
FREENOME, INC.	-0.88%	+16.87%	+27.81%	-	1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+4.22%	+51.58%	+252.65%	-18.26%	1.29B
SEEGENE, INC.	-2.40%	-5.13%	+16.63%	+41.86%	1B
HANGZHOU ALLTEST BIOTECH CO., LTD.	-2.72%	-2.82%	-36.30%	+1.72%	552M
Average	-0.80%	+9.74%	+85.91%	+85.16%	2.06B
Weighted average by Cap.	-0.77%	+10.61%	+112.99%	+140.60%